Tacrolimus and Recurrent cancer - a phase IV clinical study of FDA data

Summary:

Recurrent cancer is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Mycophenolate Mofetil, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Recurrent cancer when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Recurrent cancer?

Recurrent cancer (repeated cancer) is found to be associated with 368 drugs and 432 conditions by eHealthMe. Check the latest studies of Recurrent cancer.

On Jul, 17, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 42 people (0.04%) have Recurrent cancer.

Could Tacrolimus cause Recurrent cancer?

Among these 42 people:

How long have people been on Tacrolimus when they have Recurrent cancer? *

What is the gender of people who have Recurrent cancer when taking Tacrolimus? *

female: 52.17 %
male: 47.83 %

What is the age of people who have Recurrent cancer when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

Mycophenolate Mofetil: 16 people, 38.10%
Acyclovir: 9 people, 21.43%
Prednisolone: 4 people, 9.52%
Prednisone: 2 people, 4.76%
Amlodipine: 2 people, 4.76%
Busulfex: 2 people, 4.76%
Cyclophosphamide: 2 people, 4.76%
Cytarabine: 2 people, 4.76%
Methylprednisolone: 2 people, 4.76%
Ondansetron: 2 people, 4.76%

What are other side effects people have besides Recurrent cancer? *

Skin Cancer: 5 people, 11.90%
Cervical Dysplasia (abnormal changes in the cells on the surface of the cervix): 5 people, 11.90%
Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 4 people, 9.52%
Pneumonia: 4 people, 9.52%
Fatigue (feeling of tiredness): 4 people, 9.52%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 7.14%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 4.76%
Infection Reactivation: 2 people, 4.76%
Weight Decreased: 2 people, 4.76%
Septic Shock (shock due to blood infection): 2 people, 4.76%

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 8 people, 19.05%
Immunodeficiency Disorders: 5 people, 11.90%
Viral Infection: 1 person, 2.38%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 2.38%
Bone Marrow Conditioning Regimen: 1 person, 2.38%
Chronic Kidney Disease: 1 person, 2.38%
Chronic Myeloid Leukaemia Transformation (cancer of blood forming cells spreads to blood cells): 1 person, 2.38%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 1 person, 2.38%
Heart Transplant Rejection: 1 person, 2.38%
Multiple Myeloma (cancer of the plasma cells): 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Recurrent cancer?

- Check whether Recurrent cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,160 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Recurrent cancer:

Recurrent cancer (368 drugs)

Browse all the conditions that are associated with Recurrent cancer:

Recurrent cancer (432 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.